Baumer S.A. (BVMF:BALM3)

Market Cap	215.28M +88.6%
Revenue (ttm)	213.73M +10.0%
Net Income	18.08M -42.8%
EPS	1.85 -42.8%
Shares Out	n/a
PE Ratio	11.91
Forward PE	n/a
Dividend	4.68 (18.59%)
Ex-Dividend Date	May 4, 2026

Volume	200
Average Volume	305
Open	25.18
Previous Close	25.18
Day's Range	25.18 - 25.18
52-Week Range	16.30 - 33.00
Beta	0.36
RSI	51.31
Earnings Date	May 14, 2026

About Baumer

Baumer S.A., together with its subsidiaries, engages in the development, industrialization, trade, production, import, export, and technical assistance in products for hospitals and industries related to the health area in Brazil and internationally. The company offers orthopedic devices, such as conventional prosthesis, spine and neurosurgery, non-conventional prosthesis, trauma, and biomaterials; and hospital equipment, including CSSD, surgical center and ICU, and sterilization process monitoring. It also provides life science equipment compr...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1952
• Employees: 306
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: BALM3

Financial Performance

In 2025, Baumer's revenue was 213.73 million, an increase of 9.95% compared to the previous year's 194.39 million. Earnings were 18.08 million, a decrease of -42.81%.